AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16377978 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 x 5 g creatine monohydrate per day for 5 days)
Number of subjects: 18
Study 16377978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15253143 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic waveform (group I)
Number of subjects: 64
Study 15253143 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectilinear biphasic waveform (group II)
Number of subjects: 64
Study 15253143 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic truncated waveform (group III)
Number of subjects: 64
Study 12228196 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose involved-field radiotherapy (LD-IFRT)
Number of subjects: 501
Study 12228196 — intervention group
Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 501
Study 9589294 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐HMPAO‐white blood cell scans in patients with active CD
Number of subjects: 215
Study 9589294 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐HMPAO‐white blood cell scans in patients with active UC
Number of subjects: 215
Study 9589294 — intervention group
Group type: COMPARATOR
Intervention: 99mTc‐HMPAO‐white blood cell scans in controls
Number of subjects: 215
Study 7979858 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody against oxidized low-density lipoprotein
Number of subjects: 135
Study 7979858 — intervention group
Group type: COMPARATOR
Intervention: Lowest tertile of antibody level
Number of subjects: 135
Study 2742097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 80
Study 2742097 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 80
Study 29952687 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐Exercise (12-week blended intervention with face-to-face physiotherapy sessions and a web-based application)
Number of subjects: 123
Study 29952687 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐Exercise
Number of subjects: 123
Study 30622099 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette users
Number of subjects: 165
Study 30622099 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpipe users
Number of subjects: 165
Study 30622099 — intervention group
Group type: EXPERIMENTAL
Intervention: Nass users
Number of subjects: 165
Study 30622099 — intervention group
Group type: COMPARATOR
Intervention: Never tobacco users
Number of subjects: 165
Study 28071865 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-implementation of sepsis guidelines
Number of subjects: 165
Study 25896747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) once a week for 12 weeks
Number of subjects: 98
Study 25896747 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline startle reflex to alcohol cues
Number of subjects: 98
Study 25896747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 98
Study 25896747 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline startle reflex elicited by alcohol-associated stimuli
Number of subjects: 98
Study 23912022 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental maternally administered intervention (Hospital to Home Transition‐Optimizing Premature Infant's Environment)
Number of subjects: 142
Study 21684353 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose rosuvastatin (20mg orally for 14 days, 7 days before and after surgery) plus low-molecular-weight heparin (LMWH) (40 mg enoxaparin subcutaneously starting 12h prior to surgery and continuing for 7 days)
Number of subjects: 180
Study 21684353 — intervention group
Group type: COMPARATOR
Intervention: Conventional LMWH therapy (40 mg enoxaparin subcutaneously starting 12h prior to surgery and continuing for 7 days)
Number of subjects: 180
Study 19325478 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency percussive ventilation (HFPV)
Number of subjects: 53
Study 19325478 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 53
Study 16766543 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 4-8 mg/day
Number of subjects: 80
Study 16766543 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control)
Number of subjects: 80
Study 15004678 — intervention group
Group type: EXPERIMENTAL
Intervention: Störkel's prognostic score
Number of subjects: 129
Study 15004678 — intervention group
Group type: COMPARATOR
Intervention: TNM classification (including subdivision of stage pT1 into pT1a and pT1b)
Number of subjects: 129
Study 10791451 — intervention group
Group type: EXPERIMENTAL
Intervention: Single osmotic laxative
Number of subjects: 206
Study 10791451 — intervention group
Group type: COMPARATOR
Intervention: Osmotic agent along with a rectal stimulant and weekly enemas
Number of subjects: 206
Study 9289439 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antibodies radioimmunoassay of human cortisol binding globulin serum level
Number of subjects: 0
Study 9289439 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard curve using specific Bx/Box100%
Number of subjects: 0
Study 1847291 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered bupivicaine (0.5% with sodium bicarbonate, pH adjusted to 7.0)
Number of subjects: 62
Study 1847291 — intervention group
Group type: COMPARATOR
Intervention: Unbuffered bupivicaine (control)
Number of subjects: 62
Study 1847291 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of buffered vs unbuffered bupivicaine
Number of subjects: 62
Study 6339152 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion with glucose
Number of subjects: 17
Study 31761417 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 64
Study 31761417 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 64
Study 29846693 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative multiparametric magnetic resonance imaging (MRI) features
Number of subjects: 111
Study 29846693 — intervention group
Group type: EXPERIMENTAL
Intervention: SHH-specific nomogram
Number of subjects: 111
Study 29846693 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 nomogram
Number of subjects: 111
Study 28697202 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral zone (NZ) mandibular denture
Number of subjects: 37
Study 28697202 — intervention group
Group type: COMPARATOR
Intervention: Conventional (CV) mandibular denture
Number of subjects: 37
Study 28697202 — intervention group
Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 37
Study 25738669 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months of valganciclovir therapy
Number of subjects: 96
Study 25738669 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks of valganciclovir therapy
Number of subjects: 96
Study 23770519 — intervention group
Group type: EXPERIMENTAL
Intervention: Country-level mean length of stay
Number of subjects: 6848
Study 23770519 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay across US study sites
Number of subjects: 6848
Study 21566548 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical containing TLR2‐Regul™
Number of subjects: 115
Study 21566548 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 115
Study 19594648 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 47
Study 19594648 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 16499254 — intervention group
Group type: EXPERIMENTAL
Intervention: New patients
Number of subjects: 1834
Study 16499254 — intervention group
Group type: EXPERIMENTAL
Intervention: Previously treated patients
Number of subjects: 1834
Study 15562053 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tranexamic acid (TA) 15 mg/kg bolus over 30 min followed by IV infusion of 10 mg . kg(‐1) . h(‐1) for 12 h
Number of subjects: 80
Study 15562053 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tranexamic acid (TA) similar to TA-long but infusion discontinued 2 h after deflation, followed by oral TA 1 g after 6 and 12 h
Number of subjects: 80
Study 15562053 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TA) 1 g administered 60 min before surgery, followed by 1 g every 6 h for 18 h
Number of subjects: 80
Study 15562053 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tranexamic acid administered)
Number of subjects: 80
Study 11054523 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation (AD) started immediately after diagnosis (IAD)
Number of subjects: 26
Study 11054523 — intervention group
Group type: COMPARATOR
Intervention: Deferred treatment policy (DAD)
Number of subjects: 26
Study 9232145 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic anesthesia record keeping (EARK)
Number of subjects: 20
Study 9232145 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual recording (MAN)
Number of subjects: 20
Study 9232145 — intervention group
Group type: EXPERIMENTAL
Intervention: EARK
Number of subjects: 20
Study 9232145 — intervention group
Group type: EXPERIMENTAL
Intervention: TEE use
Number of subjects: 20
Study 9232145 — intervention group
Group type: EXPERIMENTAL
Intervention: Before intubation
Number of subjects: 20
Study 1283143 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy with additional external beam radiotherapy (30 Gy in 10-20 fractions)
Number of subjects: 22
Study 1283143 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy with additional external beam radiotherapy (40 Gy in 10-20 fractions)
Number of subjects: 22
Study 1283143 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Laser therapy + external beam radiotherapy)
Number of subjects: 22
Study 6728874 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.7 g/kg
Number of subjects: 0
Study 6728874 — intervention group
Group type: COMPARATOR
Intervention: Ethanol 0.5 g/kg
Number of subjects: 0
Study 6728874 — intervention group
Group type: COMPARATOR
Intervention: Caffeine 5 mg/kg
Number of subjects: 0
Study 6728874 — intervention group
Group type: COMPARATOR
Intervention: Ethanol 0.5 g/kg and Caffeine 5 mg/kg combined
Number of subjects: 0
Study 6728874 — intervention group
Group type: COMPARATOR
Intervention: Alcohol placebo and caffeine placebo
Number of subjects: 0
Study 6728874 — intervention group
Group type: COMPARATOR
Intervention: Alcohol placebo and caffeine
Number of subjects: 0
Study 6728874 — intervention group
Group type: COMPARATOR
Intervention: Alcohol and caffeine placebo
Number of subjects: 0
Study 6728874 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and caffeine
Number of subjects: 0
Study 3543278 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 41
Study 3543278 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 41
Study 29357332 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise protocol (mild exercise)
Number of subjects: 20
Study 26708361 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 28
Study 26708361 — intervention group
Group type: COMPARATOR
Intervention: Squatting Control
Number of subjects: 28
Study 25331894 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes group
Number of subjects: 140
Study 25331894 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic control group
Number of subjects: 140
Study 23292040 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily with itopride 50 mg three times daily
Number of subjects: 64
Study 23292040 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once daily
Number of subjects: 64
Study 20579392 — intervention group
Group type: EXPERIMENTAL
Intervention: Household-level incentives for ITN use (bonus for ITN use after visual confirmation)
Number of subjects: 21
Study 20579392 — intervention group
Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 21
Study 20579392 — intervention group
Group type: EXPERIMENTAL
Intervention: Household-level incentives for ITN use
Number of subjects: 21
Study 18065277 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-angle colonoscope (WA)
Number of subjects: 710
Study 18065277 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope (ST)
Number of subjects: 710
Study 16895634 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (5 mg/day from day 3 to day 7 of the IUI cycle)
Number of subjects: 80
Study 16895634 — intervention group
Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (HMG) (75 IU for women under 30 years old and 150 IU for women over 30 years old)
Number of subjects: 80
Study 16895634 — intervention group
Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (HMG)
Number of subjects: 80
Study 16895634 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 80
Study 15022582 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoid therapy (tretinoin) applied via iontophoresis
Number of subjects: 0
Study 15022582 — intervention group
Group type: COMPARATOR
Intervention: Topical retinoid therapy (tretinoin)
Number of subjects: 0
Study 10777006 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic density in more than 75% of breast area
Number of subjects: 888
Study 10777006 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (women with no density)
Number of subjects: 888
Study 8887606 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance-triggered system
Number of subjects: 10
Study 8887606 — intervention group
Group type: COMPARATOR
Intervention: Flow/volume-triggered system
Number of subjects: 10
Study 1984215 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin (PG) E2 gel
Number of subjects: 168
Study 1984215 — intervention group
Group type: COMPARATOR
Intervention: Double balloon device with PGE2 gel
Number of subjects: 168
Study 1984215 — intervention group
Group type: COMPARATOR
Intervention: Double balloon device with placebo gel
Number of subjects: 168
Study 1984215 — intervention group
Group type: EXPERIMENTAL
Intervention: Double balloon device alone (without PGE2)
Number of subjects: 168
Study 6337609 — intervention group
Group type: EXPERIMENTAL
Intervention: mianserin 60 mg nocte
Number of subjects: 80
Study 6337609 — intervention group
Group type: COMPARATOR
Intervention: nomifensine 150 mg daily
Number of subjects: 80
Study 30739128 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg (one capsule before surgery and one capsule once per night up till postoperative day 2)
Number of subjects: 87
Study 30739128 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one capsule before surgery and one capsule once per night up till postoperative day 2)
Number of subjects: 87
Study 30739128 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 87
Study 30739128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 30172037 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based peer delivered self-management intervention (5 home visits and 5 phone calls with a peer health coach)
Number of subjects: 400
Study 30172037 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 400
Study 27142674 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Scattering Proton Therapy (PSPT)
Number of subjects: 52
Study 27142674 — intervention group
Group type: COMPARATOR
Intervention: Intensity Modulation Radiation Therapy (IMRT)
Number of subjects: 52
Study 25372582 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 21
Study 25372582 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day
Number of subjects: 21
Study 25372582 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day and 40 mg/day combined
Number of subjects: 21
Study 23135096 — intervention group
Group type: EXPERIMENTAL
Intervention: TCA 80%
Number of subjects: 55
Study 23135096 — intervention group
Group type: COMPARATOR
Intervention: TCA 35%
Number of subjects: 55
Study 20473044 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg/d
Number of subjects: 150
Study 20473044 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine 37.5 mg/d
Number of subjects: 150
Study 20473044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 18028529 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 42
Study 18028529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 16480165 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard five-needle National Acupuncture Detoxification Association (NADA) protocol
Number of subjects: 40
Study 16480165 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced, escalating dose (one to three needle) protocol
Number of subjects: 40
Study 16480165 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with spirituality-focused group therapy
Number of subjects: 40
Study 16480165 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture without spirituality-focused group therapy
Number of subjects: 40
Study 11570836 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM intervention (three whole class lessons and three sessions with an interactive computer program)
Number of subjects: 4227
Study 11570836 — intervention group
Group type: COMPARATOR
Intervention: Control (no special intervention)
Number of subjects: 4227
Study 11570836 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM intervention
Number of subjects: 4227
Study 11570836 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 4227
Study 9459113 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 190 mg/kg/day
Number of subjects: 42
Study 9459113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 8147930 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacerhein and Tenoxicam
Number of subjects: 288
Study 8147930 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam
Number of subjects: 288
Study 8147930 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacerhein
Number of subjects: 288
Study 3202925 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (mean serum ethanol 35 mmol/l)
Number of subjects: 7
Study 3202925 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (serum ethanol 21 mmol/l)
Number of subjects: 7
Study 3202925 — intervention group
Group type: COMPARATOR
Intervention: Isovolumic, isocaloric drink
Number of subjects: 7
Study 31196759 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography-guided platinum microcoil lung surgery
Number of subjects: 92
Study 27993588 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum-focused extracorporeal shock wave therapy (energy flux density, .06‐.09mJ/mm2; pulse ratio per point, 200)
Number of subjects: 46
Study 27993588 — intervention group
Group type: COMPARATOR
Intervention: Sham-focused extracorporeal shock wave therapy (no energy)
Number of subjects: 46
Study 27993588 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 46
Study 27993588 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including verum, sham, and no intervention)
Number of subjects: 46
Study 25951632 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingying Huoxue Decoction (QHD) combined with ursodeoxycholic acid (UDCA)
Number of subjects: 78
Study 25951632 — intervention group
Group type: COMPARATOR
Intervention: ursodeoxycholic acid (UDCA) alone
Number of subjects: 78
Study 25951632 — intervention group
Group type: COMPARATOR
Intervention: Both groups (treatment and control)
Number of subjects: 78
Study 24010736 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2190915 300 mg QD (add-on to FP)
Number of subjects: 307
Study 24010736 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2190915 300 mg QD (add-on to FP/salmeterol)
Number of subjects: 307
Study 24010736 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2190915 100 mg QD (add-on to FP)
Number of subjects: 307
Study 24010736 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg QD (add-on to FP)
Number of subjects: 307
Study 24010736 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 µg BID (add-on to FP)
Number of subjects: 307
Study 24010736 — intervention group
Group type: COMPARATOR
Intervention: Placebo (add-on to FP)
Number of subjects: 307
Study 24010736 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg QD (add-on to FP/salmeterol)
Number of subjects: 307
Study 24010736 — intervention group
Group type: COMPARATOR
Intervention: Placebo (add-on to FP/salmeterol)
Number of subjects: 307
Study 21896927 — intervention group
Group type: EXPERIMENTAL
Intervention: DiaPep277
Number of subjects: 146
Study 21896927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 19517341 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Port (Bard)
Number of subjects: 40
Study 19517341 — intervention group
Group type: EXPERIMENTAL
Intervention: T-Port-Contrast (PFM)
Number of subjects: 40
Study 19517341 — intervention group
Group type: COMPARATOR
Intervention: X-Port (BARD)
Number of subjects: 40
Study 17545346 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality circles intervention (self-led meeting with material introduced by a research team member)
Number of subjects: 75
Study 17545346 — intervention group
Group type: COMPARATOR
Intervention: Standard dissemination of the guideline by mail (control group)
Number of subjects: 75
Study 17545346 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality circles intervention
Number of subjects: 75
Study 15577058 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH)
Number of subjects: 0
Study 15577058 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH and anti-resorptive agents (concurrent or sequential therapies)
Number of subjects: 0
Study 11579859 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 570
Study 11579859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 570
Study 9560175 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy plus graded exposure
Number of subjects: 74
Study 9560175 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Training plus graded exposure
Number of subjects: 74
Study 9560175 — intervention group
Group type: EXPERIMENTAL
Intervention: therapist-assisted graded exposure alone
Number of subjects: 74